Regal Rexnord Updates Shareholders on CEO Succession Efforts Progress Regal Rexnord Corporation has announced an extension for CEO Louis Pinkham as the hunt for a new leader progresses, ensuring a smooth transition and continuity.

Regal Rexnord Updates Shareholders on CEO Succession Efforts Progress #USA #Milwaukee #CEO_Succession #Regal_Rexnord #Louis_Pinkham

Deloitte's Latest Survey Unveils the 'Succession Paradox' in Family Businesses A recent Deloitte survey highlights a significant gap in succession planning among family businesses, revealing the 'succession paradox.' Learn more about the findings and implications for business leaders.

Deloitte's Latest Survey Unveils the 'Succession Paradox' in Family Businesses #United_States #New_York #Deloitte #Family_Business #CEO_Succession

Buffett's farewell letter includes his account of fingerprinting nuns when he was eight from boingboing rss feed

Buffett's farewell letter includes his account of fingerprinting nuns when he was eight
boingboing.net/2025/11/11/buffetts-fare...
#Berkshire_Hathaway #Business #CEO_succession #finance #Warren_Buffett #boingboing

Air Products' Board Showcases Strong Leadership, Governance, and Financial Growth Amid Rival Pressure Amid challenges, Air Products' Board emphasizes its robust CEO succession plan and financial success, inviting shareholders to support their nominees.

Air Products' Board Showcases Strong Leadership, Governance, and Financial Growth Amid Rival Pressure #United_States #Air_Products #Lehigh_Valley,_Pennsylvania #CEO_Succession #Board_Governance

D. E. Shaw Group Urges Air Products Board to Improve Succession Strategy Amid Concerns The D. E. Shaw Group expresses discontent with Air Products' board regarding poor CEO succession management, advocating for significant changes at the 2025 annual meeting.

D. E. Shaw Group Urges Air Products Board to Improve Succession Strategy Amid Concerns #United_States #New_York #Air_Products #CEO_Succession #D._E._Shaw

A Significant Leadership Transition at Jazz Pharmaceuticals Set for 2025 Bruce Cozadd, CEO of Jazz Pharmaceuticals, will retire by 2025, marking a pivotal leadership transition for the biopharma company.

A Significant Leadership Transition at Jazz Pharmaceuticals Set for 2025 #Ireland #Dublin #Jazz_Pharmaceuticals #Bruce_Cozadd #CEO_Succession